159 related articles for article (PubMed ID: 1981308)
1. Purine nucleosides and nucleotides as central nervous system modulators. Adenosine as the prototypic paracrine neuroactive substance.
Williams M
Ann N Y Acad Sci; 1990; 603():93-107. PubMed ID: 1981308
[No Abstract] [Full Text] [Related]
2. Presynaptic purine receptors.
Westfall DP; Shinozuka K; Forsyth KM; Bjur RA
Ann N Y Acad Sci; 1990; 604():130-5. PubMed ID: 2221704
[No Abstract] [Full Text] [Related]
3. Adenosine receptors. Roles and pharmacology.
Bruns RF
Ann N Y Acad Sci; 1990; 603():211-25; discussion 225-6. PubMed ID: 2291523
[No Abstract] [Full Text] [Related]
4. ATP- and adenosine-mediated signaling in the central nervous system: purinergic receptor complex: generating adenine nucleotide-sensitive adenosine receptors.
Yoshioka K; Nakata H
J Pharmacol Sci; 2004 Feb; 94(2):88-94. PubMed ID: 14978342
[TBL] [Abstract][Full Text] [Related]
5. [Hypothesis of the purinergic nerve].
Bai XN; Cai WQ
Sheng Li Ke Xue Jin Zhan; 1986 Jul; 17(3):205-9. PubMed ID: 2879348
[No Abstract] [Full Text] [Related]
6. Purinoceptor-mediated modulation of purine and neurotransmitter release from nervous tissue.
Di Iorio P; Ballerini P; Caciagli F; Ciccarelli R
Pharmacol Res; 1998 Mar; 37(3):169-78. PubMed ID: 9602464
[TBL] [Abstract][Full Text] [Related]
7. ATP- and adenosine-mediated signaling in the central nervous system: synaptic purinoceptors: the stage for ATP to play its "dual-role".
Kato F; Kawamura M; Shigetomi E; Tanaka J; Inoue K
J Pharmacol Sci; 2004 Feb; 94(2):107-11. PubMed ID: 14978346
[TBL] [Abstract][Full Text] [Related]
8. Purinergic inhibition of neurotransmitter release in the central nervous system.
Ribeiro JA
Pharmacol Toxicol; 1995 Nov; 77(5):299-305. PubMed ID: 8778740
[TBL] [Abstract][Full Text] [Related]
9. Cardiac effects of adenosine and ATP.
Pelleg A; Hurt CM; Michelson EL
Ann N Y Acad Sci; 1990; 603():19-30. PubMed ID: 2291521
[No Abstract] [Full Text] [Related]
10. Purinergic stimulation of cell division and differentiation: mechanisms and pharmacological implications.
Rathbone MP; Deforge S; Deluca B; Gabel B; Laurenssen C; Middlemiss P; Parkinson S
Med Hypotheses; 1992 Apr; 37(4):213-9. PubMed ID: 1625596
[TBL] [Abstract][Full Text] [Related]
11. Modulation of neurotransmission by purine nucleotides and nucleosides.
Fredholm BB; Hedqvist P
Biochem Pharmacol; 1980 Jun; 29(12):1635-43. PubMed ID: 6250541
[No Abstract] [Full Text] [Related]
12. Purinergic neurotransmission and neuromodulation.
Su C
Annu Rev Pharmacol Toxicol; 1983; 23():397-411. PubMed ID: 6135390
[TBL] [Abstract][Full Text] [Related]
13. The past, present and future of purine nucleotides as signalling molecules.
Burnstock G
Neuropharmacology; 1997 Sep; 36(9):1127-39. PubMed ID: 9364468
[No Abstract] [Full Text] [Related]
14. Purinergic receptors.
Burnstock G
J Theor Biol; 1976 Oct; 62(2):491-503. PubMed ID: 994531
[No Abstract] [Full Text] [Related]
15. Potential therapeutic targets in the rapidly expanding field of purinergic signalling.
Burnstock G
Clin Med (Lond); 2002; 2(1):45-53. PubMed ID: 11871639
[TBL] [Abstract][Full Text] [Related]
16. Purine receptors in mammalian tissues: pharmacology and functional significance.
Williams M
Annu Rev Pharmacol Toxicol; 1987; 27():315-45. PubMed ID: 3555319
[No Abstract] [Full Text] [Related]
17. Purinergic mechanisms of the nucleus of the solitary tract and neural cardiovascular control.
Scislo TJ; O'Leary DS
Neurol Res; 2005 Mar; 27(2):182-94. PubMed ID: 15829182
[TBL] [Abstract][Full Text] [Related]
18. Purinergic receptors in the heart.
Burnstock G
Circ Res; 1980 Jun; 46(6 Pt 2):I175-82. PubMed ID: 6247089
[No Abstract] [Full Text] [Related]
19. Myocardial preconditioning. Part of the adenosine revival.
Mullane K
Circulation; 1992 Feb; 85(2):845-7. PubMed ID: 1735177
[No Abstract] [Full Text] [Related]
20. Pathophysiology and pharmacology of the adenosine system.
Di Perri T; Laghi-Pasini F
Ann Ital Med Int; 1991; 6(4 Pt 2):442-7. PubMed ID: 1840810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
